About Althea Technologies
Althea Technologies is a company based in San Diego (United States) founded in 1998 by Francois Ferre was acquired by Ajinomoto in March 2013.. Althea Technologies has raised $23 million across 1 funding round from investors including Ajinomoto and Telegraph Hill Partners. Althea Technologies offers products and services including Smålån Service, Forbrukslån Service, and Refinansiering Service. Althea Technologies operates in a competitive market with competitors including Suanfarma, Enzene Biosciences, Hybio Pharmaceutical, Nephron Pharmaceuticals and Kardigan, among others.
- Headquarter San Diego, United States
- Founders Francois Ferre
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Althea Technologies
Althea Technologies offers a comprehensive portfolio of products and services, including Smålån Service, Forbrukslån Service, and Refinansiering Service. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides information on small unsecured loans up to 70,000 kroner
Offers guidance on consumer loans for various personal needs
Advises on consolidating debts for better interest rates
Funding Insights of Althea Technologies
Althea Technologies has successfully raised a total of $23M through 1 strategic funding round. The most recent funding activity was a Series C round of $23 million completed in January 2007. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series C — $23.0M
-
First Round
First Round
(09 Jan 2007)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2007 | Amount | Series C - Althea Technologies | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Althea Technologies
Althea Technologies has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Ajinomoto and Telegraph Hill Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on life science, medical device and healthcare companies
|
Founded Year | Domain | Location | |
|
Multi-category food and beverage products are manufactured globally.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Althea Technologies
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Althea Technologies
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Althea Technologies Comparisons
Competitors of Althea Technologies
Althea Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Suanfarma, Enzene Biosciences, Hybio Pharmaceutical, Nephron Pharmaceuticals and Kardigan, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Generics, nutraceuticals, and APIs are developed by Suanfarma.
|
|
| domain | founded_year | HQ Location |
Company specializing in development of Biosimilars
|
|
| domain | founded_year | HQ Location |
Polypeptide drugs and APIs are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
Sterile pharmaceutical products are manufactured and contract services are provided.
|
|
| domain | founded_year | HQ Location |
Biotech company developing personalized medicines for cardiovascular diseases
|
|
| domain | founded_year | HQ Location |
APIs and finished dosage forms are developed and manufactured.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Althea Technologies
When was Althea Technologies founded?
Althea Technologies was founded in 1998 and raised its 1st funding round 9 years after it was founded.
Where is Althea Technologies located?
Althea Technologies is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Who is the current CEO of Althea Technologies?
Francois Ferre is the current CEO of Althea Technologies. They have also founded this company.
Is Althea Technologies a funded company?
Althea Technologies is a funded company, having raised a total of $23M across 1 funding round to date. The company's 1st funding round was a Series C of $23M, raised on Jan 09, 2007.
What does Althea Technologies do?
Althea Technologies was founded in 1998 in San Diego, United States, and operates in the pharmaceutical sector as a contract manufacturer and distributor of clinical drugs and vaccines. Services provided include aseptic syringe filling, lyophilization, release testing, clinical packaging, and stability programs, supporting various clinical needs in the industry.
Who are the top competitors of Althea Technologies?
Althea Technologies's top competitors include Nephron Pharmaceuticals, Suanfarma and Enzene Biosciences.
What products or services does Althea Technologies offer?
Althea Technologies offers Smålån Service, Forbrukslån Service, and Refinansiering Service.
Who are Althea Technologies's investors?
Althea Technologies has 2 investors. Key investors include Ajinomoto, and Telegraph Hill Partners.